Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives

ACS Nano. 2018 Nov 27;12(11):10636-10664. doi: 10.1021/acsnano.8b06104. Epub 2018 Oct 23.

Abstract

The microenvironment characteristics of solid tumors, renowned as barriers that harshly impeded many drug-delivery approaches, were precisely studied, investigated, categorized, divided, and subdivided into a complex diverse of barriers. These categories were further studied with a particular perspective, which makes all barriers found in solid-tumor micromilieu turn into different types of stimuli, and were considered triggers that can increase and hasten drug-release targeting efficacy. This review gathers data concerning the nature of solid-tumor micromilieu. Past research focused on the treatment of such tumors, the recent efforts employed for engineering smart nanoarchitectures with the utilization of the specified stimuli categories, the possibility of combining more than one stimuli for much-greater targeting enhancement, examples of the approved nanoarchitectures that already translated clinically as well as the obstacles faced by the use of these nanostructures, and, finally, an overview of the possible future implementations of smart-chemical engineering for the design of more-efficient drug delivery and theranostic systems and for making nanosystems with a much-higher level of specificity and penetrability features.

Keywords: cancer cell targeting; liposomes; nanoarchitecture engineering; polymeric nanoparticles; smart nanodrug-delivery systems; smart theranostics; solid tumor micromilieu; stimuli- and trigger-responsive mechanisms.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Humans
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Tumor Microenvironment / drug effects

Substances

  • Antineoplastic Agents
  • Drug Carriers